Keep up to date on the latest medical news at MDLinx - FREE!


  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

What are Rheumatologists Really Doing Online

  
  
  
  
  

What are Rheumatologists Really Doing Online? We know, and we want to tell you.

Did you know that M3 MDLinx is the leading digital provider of clinical news and information to over 85% of all US Rheumatologists?.

Did you know that M3 MDLinx is the leading digital provider of clinical news and information to over 85% of all US Rheumatologists?

Did you know that majority of Rheumatologists actually spend more time online engaged in activities that support care for their patients than on seeking information about new medical advances in their field? Did you think the two were the same? According to Rheumatologists, they aren't.

spending their time on and offline, and what matters most to them. We surveyed over 100 Rheumatologists in the United States, who see at least 200 patients per month, and discovered not just how doctors are communicating with pharma companies, their peers and their patients, but much more. We asked them:

  • How do you want pharma and biotech companies to communicate with you in comparison to how they communicate with you today?
  • Do your pharma and biotech reps provide you with the tools and knowledge you need to best do your job? What can they do better?
  • How often and through what outlets do you interact online for research, news, social, and informational purposes?
  • How often, in what forms and for what reason do you use technology most? How can pharma brands better utilize technology?
  • If you want a basic study with stock answers that vary slightly from year to year, you shouldn't call us. But if you want the inside scoop on what Rheumatologists really want and need, and insight on how they get information and how they share it, you should contact us today.

To learn more about the details of The CompleteRheumatologist Study or purchase the report, contact MDLinx marketing@mdlinx.com to learn more.

Contact: marketing@mdlinx.com

Tags: 

Serum B-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis

  
  
  
  
  
International Journal of Rheumatic Diseases, 12/19/2012


Abdo MS et al. – To assess serum B–cell activating factor (BAFF) levels in patients with systemic sclerosis and to correlate this with disease features and disease severity. Serum BAFF levels were significantly elevated in patients with systemic sclerosis irrespective of disease subtype, disease duration or age of patients. This elevation in serum BAFF significantly related to gastrointestinal track involvement and methotrexate therapy.



Methods

    • This is a case-control study in which patients with the established diagnosis of SSc were recruited.
    • The diagnosis of SSc was established according to the American Rheumatology Association 1980 criteria for the classification of scleroderma.
    • Patients' assessment included evaluation of skin involvement using the Modified Rodnan score and disease severity using the Medsger score.
    • Twenty-five healthy matching controls were included.
    • The sandwich enzyme-linked immunosorbent assay technique was used for direct assessment of serum BAFF in patients and controls

Results


    • The study included 60 patients (54 female and 6 male), with a mean age of 38.18±12.06 years, with mean disease duration of 7.85±4.075 years.
    • Serum BAFF in patients ranged 98.2-5015 pg/mL with mean BAFF 1100±835.4 pg/mL.
    • In controls serum BAFF levels ranged 188.5-2314 pg/mL with mean BAFF 546.1±471.1 pg/mL, showing a statistically significant elevation of serum BAFF levels in SSc patients (P=0.0001) with insignificant correlation to skin disease or total Medsgar Score of the study population (P>0.05).
    • Serum BAFF levels showed significant correlation with episodes of pseudo-obstruction and methotrexate (MTX) use in the patients studied (P<0.05)



Dr Reem Hamdy A. Mohammed (12/18/2012) comments:

It is really great and we as authors are proud of having our article selected in this great scientific citation, Mdlinx team have been also active, nonreluctant and enthausiastic in encouraging spread of scientific knowledge and anchorage of research knowledge allover

More articles in rheumatology at MDLinx.com

Bisphosphates decrease risk of stroke

  
  
  
  
  
In a study involving 2148 patients on bisphosphonate therapy and 6444 matched patients with osteoporotic fractures who were followed for 2 years, the risk of stroke was significantly reduced in the former group (8.6% vs. 10.8% [HR=.79]).  Bisphosphonate users had a 0.53- and 0.81-fold risk of subarachnoid and ischemic strokes, respectively, compared to non-users.
All Posts

Trending Medical Articles

Friday, Jul 18, 2014
Obesity Surgery, 07/18/2014 Leonetti F, et al. – Researchers assessed the effectiveness of a sequential diet regimen called the "obese preoperative diet" (OPOD) in morbidly obese patients with and without type 2 diabetes mellitus (T2DM) who were scheduled to undergo laparoscopic bariatric surgery. They concluded that OPOD, including 10 days of a VLCKD, was safe and effective in...Read More
Thursday, Jul 17, 2014
International Urology and Nephrology, 07/17/2014 Chan SYS, et al. – The study aims to investigate the incidence of deep vein thrombosis (DVT) in Chinese patients undergoing robotic–assisted laparoscopic radical prostatectomy (RALP) for prostate cancer and the need for prophylactic anticoagulation. However, study suggest that the post–RALP incidence of DVT in Chinese...Read More